Analytical Data
-
Gene name
ES332_A13G234300v1
- Application
-
Species
Gossypium tomentosum
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0A5D2MNQ7
-
Expression Region
1-333aa
-
Molecular Weight
44.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The ES332_A13G234300v1 recombinant protein has garnered significant attention in the field of molecular biology and biotechnology due to its potential applications in therapeutic development and biological research. Derived from a specific organism, this protein is believed to play a crucial role in various cellular processes, including signaling pathways, enzyme functions, and interactions with other biomolecules. Understanding its structure and function is essential for elucidating its biological roles and therapeutic potentials. Recent advances in recombinant DNA technology have made it feasible to produce this protein in a controlled environment, allowing for the detailed study of its properties and applications. Researchers are exploring its potential as a biomarker for disease, as well as its utility in drug development and vaccine formulation. Additionally, the protein's interaction with cellular components could provide insights into its roles in disease mechanisms, thereby aiding in the development of targeted therapies. Overall, the ES332_A13G234300v1 recombinant protein represents a promising area of study that could lead to significant advancements in health sciences and molecular therapeutics.
